Werewolf Therapeutics Stock Market Value
| HOWL Stock | USD 0.65 0 0.54% |
| Symbol | Werewolf |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Werewolf Therapeutics. Market participants price Werewolf higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Werewolf Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Werewolf Therapeutics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Werewolf Therapeutics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Werewolf Therapeutics' market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Werewolf Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Werewolf Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Werewolf Therapeutics' market price signifies the transaction level at which participants voluntarily complete trades.
Werewolf Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Werewolf Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Werewolf Therapeutics.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Werewolf Therapeutics on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Werewolf Therapeutics or generate 0.0% return on investment in Werewolf Therapeutics over 90 days. Werewolf Therapeutics is related to or competes with IO Biotech, Spruce Biosciences, OUTLOOK THERAPEUTICS, Adicet Bio, NRX Pharmaceuticals, Lite Strategy, and OS Therapies. Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the bodys immune... More
Werewolf Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Werewolf Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Werewolf Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 51.9 | |||
| Value At Risk | (8.00) | |||
| Potential Upside | 8.7 |
Werewolf Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Werewolf Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Werewolf Therapeutics' standard deviation. In reality, there are many statistical measures that can use Werewolf Therapeutics historical prices to predict the future Werewolf Therapeutics' volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.68) | |||
| Total Risk Alpha | (1.12) | |||
| Treynor Ratio | (0.37) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Werewolf Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Werewolf Therapeutics February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | (0.36) | |||
| Mean Deviation | 4.69 | |||
| Coefficient Of Variation | (1,269) | |||
| Standard Deviation | 7.27 | |||
| Variance | 52.86 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.68) | |||
| Total Risk Alpha | (1.12) | |||
| Treynor Ratio | (0.37) | |||
| Maximum Drawdown | 51.9 | |||
| Value At Risk | (8.00) | |||
| Potential Upside | 8.7 | |||
| Skewness | (2.09) | |||
| Kurtosis | 11.71 |
Werewolf Therapeutics Backtested Returns
Werewolf Therapeutics shows Sharpe Ratio of -0.0342, which attests that the company had a -0.0342 % return per unit of risk over the last 3 months. Werewolf Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Werewolf Therapeutics' Market Risk Adjusted Performance of (0.36), standard deviation of 7.27, and Mean Deviation of 4.69 to validate the risk estimate we provide. The firm maintains a market beta of 1.57, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Werewolf Therapeutics will likely underperform. At this point, Werewolf Therapeutics has a negative expected return of -0.25%. Please make sure to check out Werewolf Therapeutics' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Werewolf Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.05 |
Very weak reverse predictability
Werewolf Therapeutics has very weak reverse predictability. Overlapping area represents the amount of predictability between Werewolf Therapeutics time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Werewolf Therapeutics price movement. The serial correlation of -0.05 indicates that only as little as 5.0% of current Werewolf Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.05 | |
| Spearman Rank Test | -0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Werewolf Therapeutics Correlation, Werewolf Therapeutics Volatility and Werewolf Therapeutics Performance module to complement your research on Werewolf Therapeutics. For more information on how to buy Werewolf Stock please use our How to buy in Werewolf Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Werewolf Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.